MTD METTLER TOLEDO INTERNATIONAL INC/
Laboratory Analytical Instruments · NYSE · SEC CIK 1037646 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2025Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.5%
TTM net income YoY11.8%
TTM EPS YoY15.0%
Revenue 3-yr CAGR2.4%
Net income 3-yr CAGR5.6%
Margins
Gross margin60.4%
Operating margin—
Net margin22.2%
FCF margin20.7%
EBITDA margin—
Returns
ROE—
ROA25.9%
ROIC (approx.)—
Asset turnover1.16x
Leverage & solvency
Liabilities / assets97.9%
Debt / equity26.06x
Current ratio1.10x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.05x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue2.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $4.03B | $3.87B | $3.79B | $3.92B | $3.72B |
| Gross profit | $2.39B | $2.33B | $2.24B | $2.31B | $2.17B |
| R&D expense | $199.37M | $189.36M | $185.28M | $177.12M | $169.77M |
| SG&A expense | $998.31M | $936.30M | $904.11M | $938.46M | $943.98M |
| Interest expense | $68.52M | $74.63M | $77.37M | $55.39M | $43.24M |
| Pretax income | $1.05B | $1.04B | $973.73M | $1.07B | $949.36M |
| Income tax | $179.72M | $174.08M | $184.95M | $198.09M | $180.38M |
| Net income | $869.19M | $863.14M | $788.78M | $872.50M | $768.99M |
| EPS (basic) | 42.17 | 40.67 | 36.10 | 38.79 | 33.25 |
| EPS (diluted) | 42.05 | 40.48 | 35.90 | 38.41 | 32.78 |
| Weighted avg. shares (diluted) | 20.67M | 21.32M | 21.97M | 22.72M | 23.46M |
| Balance sheet | |||||
| Cash & equivalents | $66.89M | $59.36M | $69.81M | $95.97M | $98.56M |
| Receivables | $778.24M | $687.11M | $663.89M | $709.32M | $647.34M |
| Inventory | $387.23M | $342.27M | $385.87M | $441.69M | $414.54M |
| Current assets | $1.36B | $1.19B | $1.23B | $1.38B | $1.27B |
| PP&E, net | $845.64M | $770.28M | $803.37M | $778.60M | $799.37M |
| Goodwill | $739.23M | $668.91M | $670.11M | $660.17M | $648.62M |
| Intangibles | $278.91M | $257.14M | $285.43M | $306.05M | $307.45M |
| Total assets | $3.71B | $3.24B | $3.36B | $3.49B | $3.33B |
| Current liabilities | $1.20B | $1.17B | $1.18B | $1.15B | $1.15B |
| Short-term debt | $63.93M | $182.62M | $192.22M | $106.05M | $101.13M |
| Long-term debt | $2.09B | $1.83B | $1.89B | $1.91B | $1.58B |
| Total debt | $2.15B | $2.01B | $2.08B | $2.01B | $1.68B |
| Total liabilities | $3.74B | $3.37B | $3.51B | $3.47B | $3.16B |
| Shareholders' equity | -$23.64M | -$126.89M | -$149.94M | $24.79M | $171.42M |
| Net debt | $2.09B | $1.95B | $2.01B | $1.92B | $1.58B |
| Shares outstanding | 22.14M | 20.95M | 21.53M | 22.14M | 22.84M |
| Cash flow statement | |||||
| Operating cash flow | $955.77M | $968.35M | $965.87M | $859.07M | $908.83M |
| Capital expenditure | $107.12M | $103.90M | $105.32M | $121.24M | $107.58M |
| Free cash flow | $848.65M | $864.45M | $860.55M | $737.83M | $801.25M |
| Investing cash flow | -$193.87M | -$119.46M | -$131.69M | -$139.40M | -$314.11M |
| Financing cash flow | -$755.17M | -$855.98M | -$859.59M | -$716.04M | -$590.55M |
| Depreciation & amortization | $51.14M | $50.35M | $48.95M | $46.78M | $44.98M |
| Stock-based compensation | $22.51M | $19.98M | $17.93M | $19.66M | $19.59M |
| Share buybacks | $800.00M | $850.00M | $900.00M | $1.10B | $1,000.00M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.